Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

7.36
-0.1400-1.87%
Volume:58.98K
Turnover:430.33K
Market Cap:157.33M
PE:-1.62
High:7.54
Open:7.54
Low:7.17
Close:7.50
Loading ...
Mar 07, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 07, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 21, 2022

Major Issues Report

8-K - Current report
Aug 26, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2022

Major Issues Report

8-K - Current report
May 17, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2022

Major Issues Report

8-K - Current report
Mar 08, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals